[{"ID":"6768_15-2021_NCT01911351","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nC: irrelevant. The patient is not eligible for the clinical trial because the trial is focused on pediatric patients undergoing minor procedures, and the patient is an adult with a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia. Additionally, the patient's condition is not related to a minor procedure, as they have been diagnosed with pancreatic adenocarcinoma and have undergone EUS with biopsy.","PROBA":0.9800121964},{"ID":"30737_65-2021_NCT02287506","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20ACE%20inhibitors%20and%20Beta%20blockers%20are%20not%20excluded%20in%20the%20clinical%20trial%20%E2%80%8B%20Therefore%2C%20the%20patient%20is%20eligible%20for%20the%20clinical%20trial.%20\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9973987974},{"ID":"5479_12-2021_NCT03686527","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because the trial is focused on myocardial function and aortic valve replacement, while the patient has mitral valve prolapse and regurgitation. The patient's condition is not related to the focus of the clinical trial. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9773638063},{"ID":"7035_15-2021_NCT04254692","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.9685086608},{"ID":"35329_75-2021_NCT00307450","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the exclusion criteria of having atypical parkinsonian syndromes. The patient has mild Parkinson's disease, which is an inclusion criterion, but the patient also has hypertension and hypercholesterolemia, which are exclusion criteria. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9806667248},{"ID":"5288_12-2021_NCT01242397","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible\n\nB: excluded\n\nC: irrelevant\n\nPlease select one of the options above.","PROBA":0.9512119338},{"ID":"30804_65-2021_NCT02816099","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9851730333},{"ID":"35706_75-2021_NCT03876327","TOPIC_YEAR":2021,"RESPONSE":"$}}%A: eligible%]  B: excluded%]  C: irrelevant%]\n\nBased on the information provided, the patient is not eligible for the clinical trial because the trial is specifically focused on treating constipation in Parkinson's disease patients, and the patient does not have a history of constipation. Additionally, the patient is already being treated with Levodopa and Trihexyphenidyl, which may make them ineligible for the trial.\n\nSo, the patient is \"excluded\" from the clinical trial.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9969145187},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the exclusion criteria of non-smokers and no history of severe hypertension. The patient has a history of hypertension, which would be considered severe, and is currently taking medication for it. Additionally, the patient's age of 67 years old is outside of the inclusion criteria of 70-85 years old. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9822454075},{"ID":"17169_36-2021_NCT02610660","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nC: irrelevant. The patient is not eligible for the clinical trial because the patient does not have pulmonary hypertension. The clinical trial is focused on tracking outcomes and practice in pediatric pulmonary hypertension, and the patient is an adult (32 years old) and does not have any condition related to pulmonary hypertension. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.9959475289},{"ID":"6703_15-2021_NCT01360918","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have atrial fibrillation?\n\nNo, the patient does not have atrial fibrillation. The patient has a history of mitral valve prolapse and is currently being treated for pancreatic adenocarcinoma.\n\n#2: Is the patient undergoing elective cardiac surgery?\n\nNo, the patient is not undergoing elective cardiac surgery. The patient is being treated for pancreatic adenocarcinoma and has a history of coronary artery disease, mitral valve prolapse, and hyperlipemia.\n\nTherefore, the patient is not eligible for the clinical trial.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.997046958},{"ID":"30417_65-2021_NCT00211510","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20ACE%20inhibitors%20and%20Beta%20blockers%20are%20not%20excluded%20in%20the%20clinical%20trial%20%E2%80%8B%20Therefore%2C%20the%20patient%20is%20eligible%20for%20the%20clinical%20trial.%20\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9979247643},{"ID":"5466_12-2021_NCT03549052","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a mitral valve lesion that needs replacement?\n\nYes, the patient has a known severe mitral valve prolapse with regurgitation, which is a type of mitral valve lesion that needs replacement.\n\n#2: Does the patient have pulmonary hypertension?\n\nYes, the patient has pulmonary hypertension, which is a requirement for inclusion in the clinical trial.\n\n#3: Is the patient's left ventricular function normal?\n\nNo, the patient has a low ejection fraction (EF) of 65%, which indicates that their left ventricular function is not normal.\n\n#4: Does the patient have any other causes of pulmonary hypertension?\n\nNo, the patient does not have any other causes of pulmonary hypertension.\n\nBased on the above, the patient is eligible for the clinical trial.\n\nSo, the answer is:\n\nA: Eligible","PROBA":0.9898691024},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20ACE%20inhibitors%20and%20Beta%20blockers%20are%20excluded%20from%20the%20study%20because%20they%20are%20not%20part%20of%20the%20study%20design.%20The%20patient%20is%20otherwise%20eligible%20for%20the%20study.%20So%2C%20the%20answer%20is%20B%20excluded.\n\nStep 1: Does the patient have type 1 diabetes? Yes\nStep 2: Is the patient at least 18 years old? No\nStep 3: Does the patient have any serious disease that could interfere with the study? No\nStep 4: Is the patient pregnant? No\nStep 5: Is the patient incompatibility with monitoring? No\nStep 6: Is the patient's diabetes irregularly managed? No\nStep 7: Does the patient have hearing loss or low vision? No\n\nTherefore, the patient is excluded from the study because they are under 18 years old.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9945088593},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a condition that is relevant to the clinical trial?\n\nThe patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia. None of these conditions are directly related to the clinical trial, which is focused on deep enteroscopy for gastrointestinal conditions. Therefore, the patient's conditions are not relevant to the clinical trial.\n\n#2: Does the patient have a condition that is listed as an exclusion criterion?\n\nThe patient is not excluded based on age, gender, or pregnancy status. However, the patient does have chronic kidney disease, which is listed as an exclusion criterion.\n\nBased on the above, the patient is not eligible for the clinical trial.","PROBA":0.9772144517},{"ID":"6882_15-2021_NCT02882503","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.7159046382},{"ID":"6848_15-2021_NCT02580422","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have pancreatic cancer?\n\nYes, the patient has pancreatic cancer, as stated in the patient note.\n\n#2: Does the patient have cachexia?\n\nYes, the patient has cachexia, as stated in the patient note.\n\n#3: Is the patient's weight loss more than 10% within 3 months prior to study entry?\n\nYes, the patient has a weight loss of more than 10% within 3 months prior to study entry, as stated in the patient note.\n\n#4: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the answer is A: eligible.","PROBA":0.9891529541},{"ID":"6620_15-2021_NCT00580749","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute pancreatitis?\n\nYes, the patient has acute pancreatitis based on the presence of abdominal pain, fever, and bandemia, which are all symptoms of the condition.\n\n#2: Is the patient's pancreatitis severe?\n\nYes, the patient's pancreatitis is severe based on the presence of a large heterogeneous mass in the head of the pancreas, which is consistent with necrotizing pancreatitis.\n\n#3: Has the patient been receiving enteral nutrition?\n\nNo, the patient has not been receiving enteral nutrition.\n\n#4: Is the patient eligible for the study based on the exclusion criteria?\n\nNo, the patient is not eligible for the study based on the exclusion criteria of chronic pancreatitis, pancreatic insufficiency requiring pancreatic enzyme supplements, pre-existing chronic renal insufficiency requiring hemodialysis or peritoneal dialysis, pre-existing end-stage liver disease with ascites, coagulopathy and encephalopathy, and pancreatic cancer proven by biopsy. The patient has acute pancreatitis and does not meet any of the exclusion criteria.\n\nTherefore, the patient is eligible for the study.","PROBA":0.992516845},{"ID":"5436_12-2021_NCT03155373","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mitral valve disease?\n\nYes, the patient has mitral valve disease, specifically severe mitral regurgitation.\n\n#2: Is the patient's primary mitral valve disease?\n\nYes, the patient's primary mitral valve disease is eligible for the clinical trial.\n\n#3: Does the patient have any exclusion criteria?\n\nYes, the patient has Marfan's syndrome, which is an exclusion criterion for the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9806182226},{"ID":"6633_15-2021_NCT00663247","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have diverticulosis or diverticular disease?\n\nYes, the patient has diverticulosis (a bulge in the bowel wall) and diverticular disease (symptoms of recurrent abdominal pain, changes in bowel habit, and incontinence).\n\n#2: Is the patient at least 60 years old?\n\nYes, the patient is 70 years old.\n\n#3: Is the patient willing and able to stop taking nonsteroidal anti-inflammatory drugs (NSAIDs) and long-term antibiotics?\n\nNo, the patient is currently taking IV antibiotics (Zosyn, then ceftriaxone and flagyl) and may not be able to stop taking them.\n\n#4: Does the patient have other gastrointestinal inflammatory conditions such as ulcerative colitis, Crohn's disease, or Coeliac disease?\n\nNo, the patient does not have these conditions.\n\nBased on the answers to these questions, the patient is not eligible for the clinical trial. The trial is specifically designed for patients with symptomatic diverticular disease who are at least 60 years old and willing and able to stop taking NSAIDs and long-term antibiotics. The patient is not currently taking these medications and has a different condition (pancreatic adenocarcinoma) that is not included in the trial.","PROBA":0.9923025403}]
